Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jenner

Showing results (161-170 of 548) with videos related to

Pageof 55
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|September 29, 2000
Endogenous dopaminergic tone and dopamine agonist actionS A Treseder, L A Smith, P Jenner
Journal of Neurochemistry|February 22, 2001
Effect of overexpression of wild-type and mutant Cu/Zn-superoxide dismutases on oxidative damage and antioxidant defences: relevance to Down's syndrome and familial amyotrophic lateral sclerosisM Lee, D Hyun, P Jenner, et al.
Journal of Neurochemistry|February 22, 2001
Effect of the overexpression of wild-type or mutant alpha-synuclein on cell susceptibility to insultM Lee, D Hyun, B Halliwell, et al.
Biochemical Pharmacology|July 25, 1991
A redox reaction between MPP+ and MPDP+ to produce superoxide radicals does not impair mitochondrial functionM J Walker, P Jenner, C D Marsden
BMJ (Clinical Research Ed.)|March 16, 1996
Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Parkinson's disease is rarely a primary cause of deathM T Silva, P M Watts, P Jenner
Biochemical Pharmacology|April 12, 1996
The isomers of thioctic acid alter C-deoxyglucose incorporation in rat basal gangliaT A Seaton, P Jenner, C D Marsden
Brain Research|June 12, 1992
Autoradiographic study of striatal D1 and D2 dopamine receptors in 6-OHDA-lesioned rats receiving foetal ventral mesencephalic grafts and chronic treatment with L-dopa and carbidopaS B Blunt, P Jenner, C D Marsden
Life Sciences|May 16, 1983
The effect of chronic neuroleptic administration on cerebral dopamine receptor functionM N Rupniak, P Jenner, C D Marsden
Psychopharmacology|January 1, 1986
Acute dystonia induced by neuroleptic drugsN M Rupniak, P Jenner, C D Marsden
The Journal of Pharmacy and Pharmacology|September 1, 1973
Letter: Preliminary investigation of the metabolism of piribedil (ET 495); a new central dopaminergic agonist and potential anti-parkinson agentP Jenner, A R Taylor, D B Campbell
Pageof 55

Showing results (161-170 of 548) with videos related to

Sort By:
Pageof 55
Movement Disorders : Official Journal of the Movement Disorder Society|September 29, 2000
Endogenous dopaminergic tone and dopamine agonist actionS A Treseder, L A Smith, P Jenner
Journal of Neurochemistry|February 22, 2001
Effect of overexpression of wild-type and mutant Cu/Zn-superoxide dismutases on oxidative damage and antioxidant defences: relevance to Down's syndrome and familial amyotrophic lateral sclerosisM Lee, D Hyun, P Jenner, et al.
Journal of Neurochemistry|February 22, 2001
Effect of the overexpression of wild-type or mutant alpha-synuclein on cell susceptibility to insultM Lee, D Hyun, B Halliwell, et al.
Biochemical Pharmacology|July 25, 1991
A redox reaction between MPP+ and MPDP+ to produce superoxide radicals does not impair mitochondrial functionM J Walker, P Jenner, C D Marsden
BMJ (Clinical Research Ed.)|March 16, 1996
Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Parkinson's disease is rarely a primary cause of deathM T Silva, P M Watts, P Jenner
Biochemical Pharmacology|April 12, 1996
The isomers of thioctic acid alter C-deoxyglucose incorporation in rat basal gangliaT A Seaton, P Jenner, C D Marsden
Brain Research|June 12, 1992
Autoradiographic study of striatal D1 and D2 dopamine receptors in 6-OHDA-lesioned rats receiving foetal ventral mesencephalic grafts and chronic treatment with L-dopa and carbidopaS B Blunt, P Jenner, C D Marsden
Life Sciences|May 16, 1983
The effect of chronic neuroleptic administration on cerebral dopamine receptor functionM N Rupniak, P Jenner, C D Marsden
Psychopharmacology|January 1, 1986
Acute dystonia induced by neuroleptic drugsN M Rupniak, P Jenner, C D Marsden
The Journal of Pharmacy and Pharmacology|September 1, 1973
Letter: Preliminary investigation of the metabolism of piribedil (ET 495); a new central dopaminergic agonist and potential anti-parkinson agentP Jenner, A R Taylor, D B Campbell
Pageof 55